NCT05783323
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05783323
Title Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Children's Hospital of Philadelphia
Indications
Therapies
Age Groups: senior | child | adult
Covered Countries USA

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field